Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
VOSPIRE ER |
| Manufacturer |
|
DAVA Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
β2-agonist. |
| Generic Name |
|
Albuterol (as sulfate) 4mg, 8mg; ext-rel tabs. |
| Indications |
|
Bronchospasm. |
| Children |
|
Swallow whole. <6 years: not recommended. ≥6 years: 4mg every 12 hours; max 24mg/day in 2 divided doses. |
| Adults |
|
Swallow whole. 4–8mg every 12 hours; max 32mg/day in 2 divided doses (every 12 hours). |
| Precautions |
|
Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Avoid MAOIs, tricyclics within 14 days (increased cardiovascular effects). Oral sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with other drugs that lower serum potassium. |
| Adverse Reactions |
|
Tremor, headache, nervousness, GI upset, tachycardia, muscle cramps, insomnia, dizziness, somnolence, weakness, CNS stimulation, difficulty in micturition, hypokalemia, paradoxical bronchospasm, rash. |
| How Supplied |
|
ER tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
